Preparation of mixed ligand immobilized artificial membranes for predicting drug binding to membranes.
Mixed ligand immobilized artificial membranes (IAMs) are surfaces that contain at least two immobilized membrane phospholipids which are designated as either the primary phospholipid or the secondary phospholipid. The primary immobilized phospholipid refers to the immobilized phospholipid that has the highest surface density. For this work, the primary immobilized phospholipid was a single-chain ether phosphatidylcholine (PC) analog. Four mixed-ligand IAMs were prepared by use of immobilized PC as the primary immobilized phospholipid. The secondary immobilized phospholipid ligand was either phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid. All of these secondary phospholipids are bonded at approximately 6-10 mol % relative to the molar amount of immobilized PC. Each secondary phospholipid contains functional groups in the polar head group region that require protecting groups during the immobilization process. The four-step synthetic strategy to prepare mixed-ligand IAMs involves (i) immobilization of the PC analog at high density to silica propylamine (SPA), (ii) immobilization of the second phospholipid (PL) analog at low density, (iii) end capping residual amines with a long-chain anhydride followed by end capping with a short-chain anhydride, and (iv) deprotection of the polar head group protecting groups. The surface density of the mixed PLs bonded to the silica support was approximately 130 mumol of PLs/g of SPA. High-performance liquid chromatography using these mixed lipid IAMs can be exploited to rapidly predict the membrane binding properties of drugs.
Pidgeon
C
C
Department of Medicinal Chemistry, School of Pharmacy, Purdue University, West Lafayette, Indiana 47907.
Ong
S
S
Choi
H
H
Liu
H
H
D000316:Adrenergic alpha-Agonists / Q000302:isolation & purification; D001665:Binding Sites; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D008024:Ligands; D008081:Liposomes; D008567:Membranes, Artificial; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism
D000316:Adrenergic alpha-Agonists; D008024:Ligands; D008081:Liposomes; D008567:Membranes, Artificial; D004364:Pharmaceutical Preparations; D010743:Phospholipids